New agent marks major expansion of Condor's AI platform, enables biopharma R&D teams to ask complex questions about their clinical programs, and instantly get answers they can act on
SAN DIEGO, Sept. 17, 2026 /PRNewswire/ -- Condor, the AI platform for biopharma R&D teams, today unveiled its new clinical finance agent that gives R&D teams the "why" behind variances, runs full what-if scenario planning, and then builds the resulting model directly in Condor. It's part of a team of agents built on Condor's clinical and financial ontology and knowledge graph with the Big 4 accounting and consulting firms. The agents automate workflows so R&D teams can make clinical and financial decisions more quickly and confidently.
Read the original article: PR Newswire